Recent News: Immunotherapy

and/or

Connect with us

25 News Items found

In the Clinic

CAR Therapy for Solid Tumors Draws Attention at Annual Cancer Conference

By Matthew Tontonoz

Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.

TAGS:

Scientific Image

Finding

Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers

By Julie Grisham

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.

TAGS:

Tumor mutation model

Roundup

Top 10 Stories of the Year, Cancer Research Edition

By Matthew Tontonoz

Take a look back at some of the year’s biggest news in cancer research.

TAGS:

2018

Finding

Adding Low-Dose Radiation Could Make CAR T Therapy More Effective, Study Finds

By Matthew Tontonoz

The treatment combination appears to boost chimeric antigen receptor (CAR) T cells’ ability to kill cancer cells in solid tumors.

TAGS:

Blue cancer cell with a target on it

In the News

Former MSK Immunologist James Allison Wins Nobel Prize in Medicine

By Matthew Tontonoz

Dr. Allison is being honored for discovering how to take the brakes off cancer-fighting immune cells.

TAGS:

James Allison

Feature

Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy

By Matthew Tontonoz

An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.

TAGS:

MSK cell manufacturing specialist Xiuyan Wang

Finding

Discovery of Unusual Cell Type Could Help Guide Immunotherapy

By Jim Stallard

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.

TAGS:

Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.

In the Clinic

Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects

By Matthew Tontonoz

The study represents 20 years of research at MSK.

TAGS:

Medical oncologist Jae Park

In the Lab

Why Do Immune Checkpoint Inhibitors Work for Only Some People with Cancer?

By Julie Grisham

Learn about why checkpoint inhibitors, a class of immunotherapy drugs, 
is paying off — but only for some patients.

TAGS:

MSK physician­scientist Luis Diaz

Announcement

FDA Approves First CAR T Cell Therapy for Leukemia

By Matthew Tontonoz

Children, teens, and young adults with leukemia that have stopped responding to chemotherapy are the first eligible to receive the new treatment.

TAGS:

Pediatric oncologist Kevin Curran with CAR T patient Esmeralda Pineda